Logo image of ADTX

ADITXT INC (ADTX) Stock Fundamental Analysis

USA - NASDAQ:ADTX - US0070258027 - Common Stock

3.48 USD
-0.6 (-14.71%)
Last: 11/19/2025, 2:57:23 PM
3.58 USD
+0.1 (+2.87%)
Pre-Market: 11/20/2025, 6:45:13 AM
Fundamental Rating

1

ADTX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 533 industry peers in the Biotechnology industry. ADTX has a bad profitability rating. Also its financial health evaluation is rather negative. ADTX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ADTX had negative earnings in the past year.
In the past year ADTX has reported a negative cash flow from operations.
ADTX had negative earnings in each of the past 5 years.
In the past 5 years ADTX always reported negative operating cash flow.
ADTX Yearly Net Income VS EBIT VS OCF VS FCFADTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

ADTX's Return On Assets of -94.95% is on the low side compared to the rest of the industry. ADTX is outperformed by 74.30% of its industry peers.
ADTX's Return On Equity of -239.53% is on the low side compared to the rest of the industry. ADTX is outperformed by 70.36% of its industry peers.
Industry RankSector Rank
ROA -94.95%
ROE -239.53%
ROIC N/A
ROA(3y)-152.11%
ROA(5y)-160.9%
ROE(3y)-396.44%
ROE(5y)-345.59%
ROIC(3y)N/A
ROIC(5y)N/A
ADTX Yearly ROA, ROE, ROICADTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADTX Yearly Profit, Operating, Gross MarginsADTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

1

2. Health

2.1 Basic Checks

ADTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ADTX has more shares outstanding
Compared to 5 years ago, ADTX has more shares outstanding
ADTX has a better debt/assets ratio than last year.
ADTX Yearly Shares OutstandingADTX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
ADTX Yearly Total Debt VS Total AssetsADTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -10.20, we must say that ADTX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -10.20, ADTX is not doing good in the industry: 72.80% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.35 indicates that ADTX is not too dependend on debt financing.
ADTX has a Debt to Equity ratio of 0.35. This is in the lower half of the industry: ADTX underperforms 70.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z -10.2
ROIC/WACCN/A
WACC10.04%
ADTX Yearly LT Debt VS Equity VS FCFADTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

ADTX has a Current Ratio of 0.02. This is a bad value and indicates that ADTX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ADTX (0.02) is worse than 98.12% of its industry peers.
A Quick Ratio of 0.02 indicates that ADTX may have some problems paying its short term obligations.
The Quick ratio of ADTX (0.02) is worse than 98.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ADTX Yearly Current Assets VS Current LiabilitesADTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

ADTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.22%, which is quite impressive.
ADTX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.62%.
EPS 1Y (TTM)81.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-30.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
ADTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 395.36% yearly.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year45.65%
Revenue Next 2Y395.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ADTX Yearly Revenue VS EstimatesADTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M 15M 20M
ADTX Yearly EPS VS EstimatesADTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -10M -20M -30M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ADTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ADTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADTX Price Earnings VS Forward Price EarningsADTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADTX Per share dataADTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500K -1M -1.5M

4.3 Compensation for Growth

ADTX's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ADTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ADITXT INC

NASDAQ:ADTX (11/19/2025, 2:57:23 PM)

Premarket: 3.58 +0.1 (+2.87%)

3.48

-0.6 (-14.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-17 2025-11-17/bmo
Earnings (Next)03-23 2026-03-23/bmo
Inst Owners1.01%
Inst Owner Change21.61%
Ins Owners0%
Ins Owner Change0%
Market Cap17.33M
Revenue(TTM)645.20K
Net Income(TTM)-31.04M
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1432.26
P/FCF N/A
P/OCF N/A
P/B 1.34
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)-1740200
EYN/A
EPS(NY)-252.96
Fwd EYN/A
FCF(TTM)-4.54
FCFYN/A
OCF(TTM)-4.54
OCFYN/A
SpS0
BVpS2.6
TBVpS2.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -94.95%
ROE -239.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.11%
ROA(5y)-160.9%
ROE(3y)-396.44%
ROE(5y)-345.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -10.2
F-Score3
WACC10.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year45.65%
Revenue Next 2Y395.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.86%
OCF growth 3YN/A
OCF growth 5YN/A

ADITXT INC / ADTX FAQ

What is the fundamental rating for ADTX stock?

ChartMill assigns a fundamental rating of 1 / 10 to ADTX.


What is the valuation status of ADITXT INC (ADTX) stock?

ChartMill assigns a valuation rating of 1 / 10 to ADITXT INC (ADTX). This can be considered as Overvalued.


Can you provide the profitability details for ADITXT INC?

ADITXT INC (ADTX) has a profitability rating of 0 / 10.


How financially healthy is ADITXT INC?

The financial health rating of ADITXT INC (ADTX) is 1 / 10.


What is the expected EPS growth for ADITXT INC (ADTX) stock?

The Earnings per Share (EPS) of ADITXT INC (ADTX) is expected to grow by 100% in the next year.